RNA - Balance Sheet - Avidity Biosciences, Inc.

Current Liabilities	98 M
Accounts Payable	8.46 M
Short-Term Debt	3.84 M
Other Current Liabilities	85.7 M
Non-Current Liabilities	40.9 M
Long-Term Debt	0
Other Non-Current Liabilities	40.9 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018
ASSETS
Cash & Cash Equivalents	219.9	185.1	340.4	405.5	328.1	94.6	3.1
Short Term Investments	1 281.6	410.3	270.3	85.1	6.7	0	0
Receivables	0	1.1	0	0.9	1.2	0	0
Inventory	0	0	1	(0.9)	(1.2)	1	0
Other Current Assets	0	14.9	8.3	5.6	3.5	1.1	0.3
Total Current Assets	1 542.3	611.3	622.9	411.1	331.7	95.7	3.2
PP&E	18.3	16.7	15.0	15.6	1.5	0.6	0.7
Intangible Assets	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0
Long Term Investments	0	0	0.3	0.3	0.3	0	0
Other Long Term Assets	3.3	0.6	0.6	0.6	0.5	0.6	38 K
Other Assets	0	0	0	0	0	0	0
Total Assets	1 563.9	628.6	638.8	427.6	333.9	96.9	4.0
LIABILITIES
Accounts Payable	8.5	8.8	4.6	2.8	7.7	2.3	1.6
Short Term Debt	3.8	14.8	6.2	3.5	0	2.8	2.7
Other Current Liabilities	64.7	39.9	60.9	28.0	3.2	1.3	0.3
Total Current Liabilities	98.0	80.7	51.9	29.7	14.6	10.2	4.6
Long Term Debt	0	6.2	15.2	19.9	1.9	2.2	7.6
Deferred Tax Income	0	0	(1.2)	(6.5)	(12.2)	134.7	0
Other Liabilities	0	0	(7.6)	(10.0)	(0.9)	45 K	32.9
Total Liabilities	138.9	127.8	60.7	46.1	27.7	162.3	45.1
EQUITY
Common Stock	12 K	8 K	7 K	5 K	4 K	1 K	0.4
Retained Earnings	(893.1)	(570.8)	(358.5)	(184.5)	(66.5)	(22.2)	(41.6)
Other Accumulative Comprehensive Income/Loss	2.9	0.1	(2.7)	(0.2)	5 K	(134.7)	(33.1)
Total Equity	1 425.0	500.8	578.1	381.4	306.2	(65.4)	(41.1)
Total Liabilities and Equity	1 563.9	628.6	638.8	427.6	333.9	96.9	4.0
SHARES OUTSTANDING
Common Shares Outstanding	111.6	73.0	52.2	41.4	21.7	37.5	20.7

Free